INVA News and Press, Innoviva Inc.

2024-07-09 13:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Everything is expensive these days including stocks. Amid a raging bull market, it is tough to find affordable stocks to buy. But they are available and it is worth the effort to track them dow...

2024-06-27 08:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding high-growth stock opportunities is crucial to constructing a stable and prosperous portfolio. Three outstanding businesses set up for remarkable development in 2024 are highlighted here...

2024-06-21 08:30:00 ET Summary Innoviva shares have increased by 25% in the past year, matching S&P 500 returns. Innoviva's financial snapshot shows revenue and net income growth, but interest expenses have increased significantly. Market assumptions suggest an optimistic ...

2024-06-18 17:01:43 ET More on Innoviva Seeking Alpha’s Quant Rating on Innoviva Historical earnings data for Innoviva Financial information for Innoviva Read the full article on Seeking Alpha For further details see: Cantor starts Innoviva...

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strate...

2024-05-31 22:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...

2024-05-12 00:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-08 17:39:32 ET More on Innoviva Armata enters $35M credit agreement with Innoviva Seeking Alpha’s Quant Rating on Innoviva Historical earnings data for Innoviva Financial information for Innoviva Read the full article on Seeking Alpha...

Core royalty platform on track; receiving GSK royalties of $61.9 million Achieved net product revenues of $19.1 million, representing 66% year-over-year growth driven by launch of XACDURO® and growth of key core product GIAPREZA® Strong pipeline progress: positive Phase ...